The evolution of diverse biological responses to DNA damage: Insights from yeast and p53

Nature Cell Biology

Volumn 3, Issue 12, 2001, Pages

  Wahl, Geoffrey M ^a   Carr, Antony M ^b  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; CELL CYCLE; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; DNA DAMAGE; GENE ACTIVATION; GENE ACTIVITY; GENE CONTROL; HUMAN; HUMAN CELL; IONIZING RADIATION; MAMMAL CELL; MITOGENESIS; MITOSIS INHIBITION; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; YEAST;

DNA DAMAGE; EVOLUTION, MOLECULAR; TUMOR SUPPRESSOR PROTEIN P53; YEASTS;

ANIMALIA; MAMMALIA;

EID: 0035195557     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb1201-e277     Document Type: Review

References (162)

1. Sensing and responding to DNA damage
2. Checkpoints: Controls that ensure the order of cell cycle events
3. Identification and characterisation of new elements involved in checkpoints and feedback controls in fission yeast
4. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae
5. A Rad3-Rad26 complex responds to DNA damage independently of other checkpoint proteins
6. S-phase-specific activation of Cds1 kinase defines a subpathway of the checkpoint response in Schizosaccharomyces pombe
7. Analysis of Rad3 and Chk1 protein kinases defines different checkpoint responses
8. Rad53-dependent phosphorylation of Swi6 and down-regulation of CLN1 and CLN2 transcription occur in response to DNA damage in Saccharomyces cerevisiae
9. Control of the DNA damage checkpoint by chk1 and rad53 protein kinases through distinct mechanisms
10. Delayed initiation of DNA synthesis in irradiated human diploid cells
11. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts
12. Participation of p53 protein in the cellular response to DNA damage
13. Sensitivity of human diploid fibroblast cell strains from various genetic disorders to acute and protracted radiation exposure
14. In vitro radiosensitivity of human diploid fibroblasts derived from patients with unusual clinical responses to radiation
15. Maintaining genetic stability through TP53 mediated checkpoint control
16. Double-strand-break-induced homologous recombination in mammalian cells
17. The molecular basis for cell cycle delays following ionizing radiation: A review
18. Biochemistry of DNA lesions
19. Radiation carcinogenesis
20. The complexity of p53 modulation: Emerging patterns from divergent signals
21. Thymocyte apoptosis induced by p53-dependent and independent pathways
22. p53 is required for radiation-induced apoptosis in mouse thymocytes
23. p53 signaling and cell cycle checkpoints
24. Surfing the p53 network
25. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes
26. Induction of apoptosis in HeLa cells by trans-activation-deficient p53
27. Essential role for p53-mediated transcription in E1A-induced apoptosis
28. Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells
29. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling
30. Defying death after DNA damage
31. p53-dependent apoptosis pathways
32. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser46-phosphorylated p53
33. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family
34. PUMA, a Novel Proapoptotic Gene, Is Induced by p53
35. PUMA induces the rapid apoptosis of colorectal cancer cells
36. Apaf-1 is a transcriptional target for E2F and p53
37. A transactivation-deficient mouse model provides insights into Trp53 regulation and function
38. p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage
39. WAF1, a potential mediator of p53 tumor suppression
40. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
41. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression
42. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage
43. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays
44. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a
45. A role for p53 in base excision repair
46. Structural and functional involvement of p53 in BER in vitro and in vivo
47. The p53 pathway
48. Dial 9-1-1 for p53: Mechanisms of p53 activation by cellular stress
49. Regulation of the p53 tumor suppressor protein
50. p53 regulation by post-translational modification and nuclear retention in response to diverse stresses
51. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain
52. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment
53. How p53 binds DNA as a tetramer
54. The p53 protein is an unusually shaped tetramer that binds directly to DNA
55. A leucine-rich nuclear export signal in the p53 tetramerization domain: Regulation of subcellular localization and p53 activity by NES masking
56. The MDM2 RING-finger domain is required to promote p53 nuclear export
57. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53
58. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
59. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase
60. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53
61. Mdm2 promotes the rapid degradation of p53
62. Regulation of p53 stability by Mdm2
63. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
64. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
65. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain
66. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
67. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
68. Mapping of the p53 and mdm-2 interaction domains
69. JNK targets p53 ubiquitination and degradation in nonstressed cells
70. Proteolytic cleavage of human p53 by calpain: A potential regulator of protein stability
71. Oligomerization is required for p53 to be efficiently ubiquitinated by MDM2
72. Sequence-specific DNA binding by p53: Identification of target sites and lack of binding to p53 - MDM2 complexes
73. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome- mediated degradation
74. Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination
75. Mdm2 mutant defective in binding p300 promotes ubiquitination but not degradation of p53: Evidence for the role of p300 in integrating ubiquitination and proteolysis
76. The 400 kDa subunit of the PCAF histone acetylase complex belongs to the ATM superfamily
77. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage
78. Synergistic activation of transcription by CBP and p53
79. Human mdm2 Mediates Multiple Mono-ubiquitination of p53 by a Mechanism Requiring Enzyme Isomerization
80. Identification of a sequence element from p53 that signals for Mdm2- targeted degradation
81. The Corepressor mSin3a Interacts with the Proline-Rich Domain of p53 and Protects p53 from Proteasome-Mediated Degradation
82. The contribution of the acidic domain of MDM2 to p53 and MDM2 stability
83. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53
84. p300/MDM2 complexes participate in MDM2-mediated p53 degradation
85. High level expression of deltaN-p63: A mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?
86. Evolution of functions within the p53/p63/p73 family
87. Regulation and activation of p53 and its family members
88. ATM-dependent phosphorylation of Mdm2 on serine 395: Role in p53 activation by DNA damage
89. The ARF/p53 pathway
90. Nucleolar Arf sequesters Mdm2 and activates p53
91. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus
92. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
93. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice
94. Ataxia-telangiectasia: Is ATM a sensor of oxidative damage and stress?
95. Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function
96. Ataxia-telangiectasia: Chronic activation of damage-responsive functions is reduced by alpha-lipoic acid
97. Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption, and ribonucleotide depletion
98. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
99. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
100. A critical role for telomeres in suppressing and facilitating carcinogenesis
101. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis
102. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2
103. ATM and ATR: Networking cellular responses to DNA damage
104. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53
105. Enhanced phosphorylation of p53 by ATM in response to DNA damage
106. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53
107. A role for ATR in the DNA damage-induced phosphorylation of p53
108. Phosphorylation of p53 serine 15 increases interaction with CBP
109. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
110. Phosphorylation of murine p53 at ser-18 regulates the p53 responses to DNA damage
111. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
112. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites
113. DNA damage-induced activation of p53 by the checkpoint kinase Chk2
114. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53
115. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2
116. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage
117. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome
118. Regulation of p53 function and stability by phosphorylation
119. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins
120. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation
121. p14ARF links the tumour suppressors RB and p53
122. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor
123. A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection
124. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
125. Differential induction of transcriptionally active p53 following UV or ionizing radiation: Defects in chromosome instability syndromes?
126. p53-mediated accumulation of hypophosphorylated pRb after the G1 restriction point fails to halt cell cycle progression
127. Disruption of epithelial cell-matrix interactions induces apoptosis
128. Radiation-induced senescence-like growth arrest requires TP53 function but not telomere shortening
129. Control of radiation-induced G1 arrest by cell-substratum interactions
130. Prolonged cell cycle arrest in irradiated human diploid skin fibroblasts: The role of nutrient deprivation
131. Cellular senescence after single and repeated balloon catheter denudations of rabbit carotid arteries
132. Pre-TCR signaling and inactivation of p53 induces crucial cell survival pathways in pre-T cells
133. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors
134. p53: Death star
135. Kinetics of p53 Binding to Promoter Sites in vivo
136. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases
137. Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment
138. Drosophila p53 is a structural and functional homolog of the tumor suppressor p53
139. Drosophila p53 binds a damage response element at the reaper locus
140. Identification and characterization of a p53 homologue in Drosophila melanogaster
141. mus304 encodes a novel DNA damage checkpoint protein required during Drosophila development
142. Guardian ancestry: Fly p53 and damage-inducible apoptosis
143. Generation of oscillations by the p53-Mdm2 feedback loop: A theoretical and experimental study
144. Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation
145. Regulation of p53 by hypoxia: Dissociation of transcriptional repression and apoptosis from p53-dependent transactivation
146. Hypoxia induces accumulation of p53 protein, but activation of a G1- phase checkpoint by low-oxygen conditions is independent of p53 status
147. Tumor hypoxia: Its impact on cancer therapy
148. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
149. E1A signaling to p53 involves the p19(ARF) tumor suppressor
150. Induction of apoptosis in fibroblasts by c-myc protein
151. Mediation of c-Myc-induced apoptosis by p53
152. The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle
153. Transient excess of MYC activity can elicit genomic instability and tumorigenesis
154. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability
155. Overexpression of c-myc precedes amplification of the gene encoding dihydrofolate reductase
156. Dephosphorylation of p53 at Ser20 after cellular exposure to low levels of non-ionizing radiation
157. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation
158. Redox-dependent signal transduction
159. Opposing effects of Ras on p53: Transcriptional activation of mdm2 and induction of p19ARF
160. JunD protects cells from p53-dependent senescence and apoptosis
161. Replication fork pausing and recombination or "gimme a break"
162. Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress